Ramucirumab in advanced hepatocellular carcinoma and elevated alpha-fetoprotein following sorafenib: outcomes by prior transarterial chemoembolisation from two randomised, double-blind, placebo-controlled phase 3 studies (REACH-2 and REACH)

T. Meyer, R. Finn, M. Kudo, Y. Kang, C. Yen, P. Galle, J. Llovet, E. Assenat, G. Brandi, K. Motomura, T. Okusaka, R. Hubner, M. Karwal, A. Baron, M. Ikeda, K. Liang, C. Wang, R. Widau, W. Schelman, A. Zhu

研究成果: Article同行評審

頁(從 - 到)iv133
期刊Annals of oncology : official journal of the European Society for Medical Oncology
出版狀態Published - 2019 七月 1

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology